These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33529734)

  • 1. Automated quantification of opioid withdrawal in neonatal rat pups using Ethovision® XT software.
    Kulbeth HJ; Fukuda S; Brents LK
    Neurotoxicol Teratol; 2021; 84():106959. PubMed ID: 33529734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists.
    Zhu H; Barr GA
    Psychopharmacology (Berl); 2000 Jun; 150(3):325-36. PubMed ID: 10923761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased myelin-related gene expression in the nucleus accumbens during spontaneous neonatal opioid withdrawal in the absence of long-term behavioral effects in adult outbred CFW mice.
    Borrelli KN; Wingfield KK; Yao EJ; Zamorano CA; Sena KD; Beierle JA; Roos MA; Zhang H; Wachman EM; Bryant CD
    Neuropharmacology; 2023 Dec; 240():109732. PubMed ID: 37774943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome.
    Tobacyk J; Parks BJ; Salazar P; Coward LU; Berquist MD; Gorman GS; Brents LK
    Drug Alcohol Depend; 2023 Aug; 249():110832. PubMed ID: 37385117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opiate withdrawal in the neonatal rat: relationship to duration of treatment and naloxone dose.
    Ceger P; Kuhn CM
    Psychopharmacology (Berl); 2000 Jun; 150(3):253-9. PubMed ID: 10923752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome.
    Griffin BA; Caperton CO; Russell LN; Cabanlong CV; Wilson CD; Urquhart KR; Martins BS; Zita MD; Patton AL; Alund AW; Owens SM; Fantegrossi WE; Moran JH; Brents LK
    J Pharmacol Exp Ther; 2019 Jul; 370(1):9-17. PubMed ID: 31028107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
    Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
    JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal continuous oral oxycodone self-administration alters pup affective/social communication but not spatial learning or sensory-motor function.
    Zanni G; Robinson-Drummer PA; Dougher AA; Deutsch HM; DeSalle MJ; Teplitsky D; Vemulapalli A; Sullivan RM; Eisch AJ; Barr GA
    Drug Alcohol Depend; 2021 Apr; 221():108628. PubMed ID: 33761428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning.
    Manigault AW; Sheinkopf SJ; Silverman HF; Lester BM
    JAMA Netw Open; 2022 Oct; 5(10):e2238783. PubMed ID: 36301544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid withdrawal behavior in spiny mice: A novel preclinical model of neonatal opioid withdrawal syndrome (NOWS).
    Stevens S; Mohan S
    Heliyon; 2021 Apr; 7(4):e06694. PubMed ID: 33898824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches.
    McPhail BT; Emoto C; Butler D; Fukuda T; Akinbi H; Vinks AA
    J Clin Pharmacol; 2021 Jul; 61(7):857-870. PubMed ID: 33382111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental DNA methylation profiles in opioid-exposed pregnancies and associations with the neonatal opioid withdrawal syndrome.
    Radhakrishna U; Vishweswaraiah S; Uppala LV; Szymanska M; Macknis J; Kumar S; Saleem-Rasheed F; Aydas B; Forray A; Muvvala SB; Mishra NK; Guda C; Carey DJ; Metpally RP; Crist RC; Berrettini WH; Bahado-Singh RO
    Genomics; 2021 May; 113(3):1127-1135. PubMed ID: 33711455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of opioid receptors in morphine withdrawal in the infant rat.
    McPhie AA; Barr GA
    Brain Res Dev Brain Res; 2000 Nov; 124(1-2):73-80. PubMed ID: 11113514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of morphine withdrawal on micro-opioid receptor-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate autoradiography in rat brain.
    Kirschke C; Schadrack J; Zieglgänsberger W; Spanagel R
    Eur J Pharmacol; 2002 Jun; 446(1-3):43-51. PubMed ID: 12098584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gestational buprenorphine exposure: Effects on pregnancy, development, neonatal opioid withdrawal syndrome, and behavior in a translational rodent model.
    Wallin CM; Bowen SE; Roberge CL; Richardson LM; Brummelte S
    Drug Alcohol Depend; 2019 Dec; 205():107625. PubMed ID: 31706250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential problems and solutions of opioid-based treatment in neonatal opioid withdrawal syndrome (NOWS): a scoping review protocol.
    Mills-Huffnagle S; Nyland JE
    BMJ Open; 2023 Feb; 13(2):e067883. PubMed ID: 36806065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal and iatrogenic neonatal opioid withdrawal syndrome: Differences and similarities in recognition, management, and consequences.
    Isaac L; van den Hoogen NJ; Habib S; Trang T
    J Neurosci Res; 2022 Jan; 100(1):373-395. PubMed ID: 33675100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age.
    Bakhireva LN; Holbrook BD; Shrestha S; Leyva Y; Ashley M; Cano S; Lowe J; Stephen JM; Leeman L
    Early Hum Dev; 2019 Jan; 128():69-76. PubMed ID: 30554024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach. Part II: The clinical application of nonpharmacologic care for NAS/NOWS.
    Velez ML; Jordan C; Jansson LM
    Neurotoxicol Teratol; 2021; 88():107032. PubMed ID: 34600100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiorespiratory anomalies and increased brainstem microglia in a rat model of neonatal opioid withdrawal syndrome.
    Osborne A; Mayer CA; Hoffman A; Cali V; Hyzny R; Lewis SJ; MacFarlane PM
    Respir Physiol Neurobiol; 2022 Feb; 296():103800. PubMed ID: 34626831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.